Cerebral blindness in association with cis-platinum chemotherapy for advanced carcinoma of the fallopian tube

Sharon B. Diamond, Steven H. Rudolph, Stephane S. Lubicz, Gunter Deppe, Carmel J. Cohen

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

A 62-year-old woman with a diagnosis of metastatic fallopian tube carcinoma was treated with cis-platinum and doxorubicin (Adriamycin) at a dosage of 50 mg/m2intravenously every 3 weeks. After the 10th course of cis-platinum and doxorubicin, she complained of headache and inability to see. Physical examination was compatible with cortical blindness. The brain scan and computed tomographic scan were normal. Visual evoked potentials showed a delay in latency. Visual acuity completely returned over the next months, but right homonymous hemianopia persists. The temporal relationship between the findings and the treatment with platinum implicates this drug as the possible causative agent in the cortical blindness.

Original languageEnglish
Pages (from-to)84S-86S
JournalObstetrics and Gynecology
Volume59
Issue number6
StatePublished - Jun 1982
Externally publishedYes

Fingerprint

Dive into the research topics of 'Cerebral blindness in association with cis-platinum chemotherapy for advanced carcinoma of the fallopian tube'. Together they form a unique fingerprint.

Cite this